In liver fibrosis, PRO-C3 levels increase with the progression of fibrosis, and it has been successfully used as a non-invasive biomarker to assess the liver fibrosis stage, which is usually assessed with a biopsy12,30. This evidence concerns the gene C3 and Hepatic fibrosis.